Refeeding Syndrome

← Back to Index (Nutrition)

Definition and Core Concepts

Refeeding syndrome occurs during the reintroduction of nutrition in a malnourished patient.
The nutrition can be provided via oral, enteral, or parenteral routes.
Parenteral feeding carries the highest risk for precipitating this syndrome.
Rapid electrolyte and fluid shifts occur in response to an insulin surge.
This insulin surge is triggered by the new presence of nutrients.
These shifts can lead to numerous severe medical complications.
The condition may progress to life-threatening outcomes.
These fatal outcomes include coma, heart failure, and sudden death.

Nutrition Recovery Syndrome

This is a related concept describing an apparent clinical worsening during therapy.
It is marked by an increase in liver size, hypertrichosis, and gynecomastia.
Parotid swelling, abdominal distension, ascites, and splenomegaly may occur.
Eosinophilia and an encephalitis-like picture are also documented.
Self-limited tremors during treatment are known as the 'kwashi shake'.
This is considered a self-limited condition.
It is attributed to excess hormones secreted during recovery rather than dietary protein excess.
Dysmyelination, vitamin deficiencies, and neurotransmitter imbalances are possible underlying causes.
A high solute load on the kidneys is another contributing factor.
The term 'refeeding syndrome' is specifically used when hypophosphatemia is present.
In clinical practice, the child should be observed carefully.
Nutritional therapy must be continued despite these transient signs.

Pathophysiology

The primary mechanism involves an increase in the supply of energy.
This energy is usually in the form of carbohydrates.
This supply is accompanied by a sudden increase in sodium pump activity.
Too sudden a supply risks causing a rapid release of accumulated intracellular sodium.
This causes a rapid expansion of extracellular and plasma volumes.
Concurrently, there is an increased cellular uptake of glucose.
Potassium, magnesium, and phosphate are also driven rapidly into the cells.
Metabolic pathways for adenosine triphosphate (ATP) production are reactivated.
This reactivation further depletes serum phosphorus levels.

Risk Factors and High-Risk Populations

Risk is greatest within the first 7 days of the start of feeding.
Low body weight is identified as the primary risk factor.
The initial caloric load is less predictive of risk than the degree of weight loss.
Early accounts of the syndrome were among starved survivors of wartime sieges.
Prisoners of war also developed this when given sudden access to unlimited food.

Vulnerable Patient Populations

Patients with anorexia nervosa and other restrictive eating disorders.
Patients with chronic conditions causing malnutrition, such as cancer or congenital heart disease.
Patients with malabsorptive syndromes, including inflammatory bowel disease and cystic fibrosis.
Patients with cerebral palsy.
Patients with a history of bariatric surgery or bowel resections.

National Institutes for Clinical Excellence (NICE) Guidelines

The NICE guidelines help identify patients at high risk for developing refeeding syndrome.

High Risk Criteria (One or more present)	Moderate Risk Criteria (Two or more present)
Body Mass Index (BMI) < 16 kg/m2	BMI < 18.5 kg/m2
Unintentional weight loss > 15% in the previous 3 to 6 months	Unintentional weight loss > 10% in the previous 3 to 6 months
Little or no nutritional intake for > 10 days	Little or no nutritional intake for > 5 days
Low levels of potassium, phosphorus, or magnesium before refeeding	History of alcohol or drug use
Not Applicable	History of using insulin, chemotherapy, antacids, or diuretics

Clinical Manifestations and Complications

The clinical signs of refeeding syndrome span multiple organ systems. They are primarily driven by specific electrolyte shifts and vitamin deficiencies.

Pathological State	Organ System	Clinical Signs and Symptoms
Hypophosphatemia	Cardiac	Hypotension, decreased stroke volume, death.
	Respiratory	Impaired diaphragm contractility, dyspnea, respiratory failure.
	Neurologic	Paresthesia, weakness, confusion, disorientation, lethargy, areflexic paralysis, seizures, coma.
	Hematologic	Leukocyte dysfunction, hemolysis, thrombocytopenia.
Hypokalemia	Cardiac	Arrhythmias.
	Respiratory	Respiratory failure.
	Neurologic	Weakness, paralysis.
	Gastrointestinal	Nausea, vomiting, constipation.
	Muscular	Rhabdomyolysis, muscle necrosis.
Hypomagnesemia	Cardiac	Arrhythmias, death.
	Neurologic	Weakness, tremor, tetany, seizures, altered mental status, coma.
	Gastrointestinal	Nausea, vomiting, diarrhea.
	Other	Refractory hypokalemia, refractory hypocalcemia.
Thiamine/Vitamin Deficiency	Neurologic/Metabolic	Encephalopathy, lactic acidosis, death.
Sodium Retention	Cardiac/Pulmonary	Fluid overload, pulmonary edema, cardiac compromise.
Hyperglycemia	Systemic	Hypotension, hypercapnia, respiratory failure, ketoacidosis, coma, dehydration, impaired immune function.

Prevention and Management

Dietary Advancement

In Severe Acute Malnutrition (SAM), pushing nutrition too quickly risks inducing the syndrome.
Treatment must proceed in an ordered progression.
The metabolic machinery must be repaired before attempting to promote weight gain.
A controlled transition over 3 days is recommended when moving from stabilization to rehabilitation phases.
This transition helps prevent refeeding syndrome.
Historically, lower-calorie refeeding with cautious advancement was the standard key to prevention.
Starting diets at 1000 to 1200 calories per day were widely recommended.
Diets as low as 500 calories per day were historically recommended in Europe.
These cautious approaches are still strictly recommended for patients with extreme malnutrition.
Extreme malnutrition is defined as less than 60% of the median BMI for age and sex.

Nuances in Adolescent Management

In the United States, the majority of hospitalized patients are adolescents with acute, moderate malnutrition.
In this specific population, studies have demonstrated the feasibility of higher-calorie refeeding.
Refeeding beginning at greater than 1400 calories per day is documented.
Randomized clinical trials show efficacy and safety in starting with 2000 calories per day.
This applies to hospitalized adolescents with moderate malnutrition secondary to anorexia nervosa.

Electrolyte Monitoring and Repletion

Serum electrolyte levels must be monitored daily in hospital settings.
Electrolyte shifts are often lower than expected when using structured protocols.
Decreased electrolyte levels must be corrected promptly with supplementation.
Declining electrolytes that remain within the normal range generally do not require treatment.

Specific Repletion Guidelines

The following guidance is suggested for electrolyte repletion in adolescents with eating disorders.

Electrolyte	Severity Level	Treatment / Action Required
Phosphorus	2.5 to 2.9 mg/dL	Phos-Na-K 1 packet (250 mg) three times a day.
	2.0 to 2.4 mg/dL	Phos-Na-K 2 packets (500 mg) three times a day.
	< 2.0 mg/dL	IV Na-K-Phos 0.24 mmol/kg (max 15 mmol/dose). Consider intensive care consultation.
Potassium	3.1 to 3.4 mmol/L	Extended release KCl 20 mEq PO. Recheck in 8 to 12 hours.
	2.5 to 3.0 mmol/L	Extended release KCl 40 mEq PO. Recheck in 8 to 12 hours.
	2.2 to 2.4 mmol/L	Extended release KCl 40 mEq PO stat.
	< 2.2 mmol/L	IV KCl. Consider intensive care consultation.
Magnesium	1.3 to 1.7 mg/dL	Magnesium oxide 1 tablet (133 to 200 mg elemental Mg) twice a day.
	1.0 to 1.2 mg/dL	Magnesium oxide 2 tablets twice a day.
	< 1.0 mg/dL	IV Mg-SO4 at 50 mg/kg (max 2 g/dose). Consider intensive care consultation.